Related Experiment Video
Updated: Apr 15, 2026

Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
Published on: July 23, 2017
Bioengineered stem cells as an alternative for islet cell transplantation
Sarah J Moore1, Boris L Gala-Lopez1, Andrew R Pepper1
1Sarah J Moore, Boris L Gala-Lopez, Andrew R Pepper, Rena L Pawlick, AM James Shapiro, Alberta Diabetes Institute, University of Alberta, Edmonton AB T6G 2E1, Canada.
Abstract:
Type 1 diabetes is an autoimmune and increasingly prevalent condition caused by immunological destruction of beta cells. Insulin remains the mainstay of therapy. Endeavours in islet transplantation have clearly demonstrated that type 1 diabetes is treatable by cellular replacement. Many challenges remain with this approach. The opportunity to use bioengineered embryonic or adult pluripotential stem cells, or islets derived from porcine xenograft sources could address future demands, but are still associated with considerable challenges. This detailed review outlines current progress in clinical islet transplantation, and places this in perspective for the remarkable scientific advances now occurring in stem cell and regenerative medicine approaches in the treatment of future curative treatment of diabetes.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
EPS and iPS Cells in Disease Research

